Dapagliflozin in heart failure: new frontiers

被引:5
|
作者
Tromp, Jasper [1 ,2 ,3 ]
Collins, Sean P. [4 ]
机构
[1] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
[2] Duke NUS Med Sch, Dept Cardiol, Singapore, Singapore
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[4] Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN USA
关键词
D O I
10.1002/ejhf.1633
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article refers to 'The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics', by J.J.V. McMurray et al., published in this issue on pages 1402-1411.
引用
收藏
页码:1412 / 1414
页数:3
相关论文
共 50 条
  • [1] Dapagliflozin (Farxiga) - A New Indication for Heart Failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1601): : 102 - 103
  • [2] Dapagliflozin and heart failure
    Spinar, Jindrich
    Spinarova, Lenka
    Vitovec, Jiri
    COR ET VASA, 2020, 62 (06) : 618 - 623
  • [3] Dapagliflozin for heart failure
    Begg, Alan
    PRACTICAL DIABETES, 2021, 38 (02) : 6 - +
  • [4] CONGESTIVE-HEART-FAILURE - NEW FRONTIERS
    PARMLEY, WW
    CHATTERJEE, K
    FRANCIS, GS
    FIRTH, BG
    KLONER, RA
    WESTERN JOURNAL OF MEDICINE, 1991, 154 (04): : 427 - 441
  • [5] Physical Exercise and MicroRNAs: New Frontiers in Heart Failure
    Fernandes-Silva, Miguel Morita
    Carvalho, Vagner Oliveira
    Guimaraes, Guilherme Veiga
    Bacal, Fernando
    Bocchi, Edimar Alcides
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 98 (05) : 459 - 466
  • [6] Biomarkers for the diagnosis and management of heart failure: new frontiers
    Vergaro, Giuseppe
    Castiglione, Vincenzo
    Aimo, Alberto
    Prontera, Concetta
    Musetti, Veronica
    Masotti, Silvia
    Giannelli, Elena
    Maltinti, Maristella
    Passino, Claudio
    Emdin, Michele
    GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (05) : 386 - 396
  • [7] Evaluation of dapagliflozin in the treatment of heart failure
    Sotirakos, Sara
    FUTURE CARDIOLOGY, 2020, 17 (03) : 415 - 425
  • [8] An update on dapagliflozin for the treatment of heart failure
    Akinci, B.
    DRUGS OF TODAY, 2021, 57 (02) : 77 - 88
  • [9] Dapagliflozin for heart failure - is it a class effect?
    Raj, Gerard Marshall
    Wyawahare, Mukta
    FUTURE CARDIOLOGY, 2020, 17 (02) : 355 - 361
  • [10] Dapagliflozin in the prevention and treatment of heart failure
    Egocheaga, I
    Escobar, C.
    Pallares, V
    Obaya, J. C.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 : 11 - 17